DE602007001656D1 - Verfahren zum Ermitteln der Wirksamkeit eines Anthracyclin-Antikrebsmittels - Google Patents

Verfahren zum Ermitteln der Wirksamkeit eines Anthracyclin-Antikrebsmittels

Info

Publication number
DE602007001656D1
DE602007001656D1 DE200760001656 DE602007001656T DE602007001656D1 DE 602007001656 D1 DE602007001656 D1 DE 602007001656D1 DE 200760001656 DE200760001656 DE 200760001656 DE 602007001656 T DE602007001656 T DE 602007001656T DE 602007001656 D1 DE602007001656 D1 DE 602007001656D1
Authority
DE
Germany
Prior art keywords
anticancer agent
determining
anthracycline anticancer
susceptibility
efficacy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE200760001656
Other languages
English (en)
Inventor
Amane Harada
Tomokazu Yoshida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sysmex Corp
Original Assignee
Sysmex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sysmex Corp filed Critical Sysmex Corp
Publication of DE602007001656D1 publication Critical patent/DE602007001656D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/44—Multiple drug resistance
DE200760001656 2006-11-13 2007-11-07 Verfahren zum Ermitteln der Wirksamkeit eines Anthracyclin-Antikrebsmittels Active DE602007001656D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006307276A JP4795203B2 (ja) 2006-11-13 2006-11-13 アンスラサイクリン系抗癌剤の感受性判定方法及びそのシステム

Publications (1)

Publication Number Publication Date
DE602007001656D1 true DE602007001656D1 (de) 2009-09-03

Family

ID=38969820

Family Applications (1)

Application Number Title Priority Date Filing Date
DE200760001656 Active DE602007001656D1 (de) 2006-11-13 2007-11-07 Verfahren zum Ermitteln der Wirksamkeit eines Anthracyclin-Antikrebsmittels

Country Status (5)

Country Link
US (1) US7718393B2 (de)
EP (1) EP1921170B1 (de)
JP (1) JP4795203B2 (de)
AT (1) ATE437241T1 (de)
DE (1) DE602007001656D1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012517238A (ja) * 2009-02-11 2012-08-02 カリス エムピーアイ インコーポレイテッド 腫瘍の分子プロファイリング法
US8546091B2 (en) * 2009-05-22 2013-10-01 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services AKT phosphorylation at Ser473 as an indicator for taxane-based chemotherapy
JP5830249B2 (ja) * 2010-03-31 2015-12-09 シスメックス株式会社 癌細胞のアンスラサイクリン系抗癌剤への感受性の判定方法及びコンピュータプログラム

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE427494T1 (de) * 2000-04-14 2009-04-15 Ventana Med Syst Inc Verfahren zur quantifizierung der akt-protein- expression
CA2504042A1 (en) * 2002-11-05 2004-05-27 The Regents Of The University Of California Methods and materials for examining pathways associated with glioblastoma progression
DE03808454T1 (de) * 2002-12-11 2006-01-26 Ventana Medical Systems, Inc., Tucson Verfahren zur voraussage der auswirkung der her2-gezielten therapie
WO2004074445A2 (en) * 2003-02-17 2004-09-02 Cold Spring Harbor Laboratory Model for studying the role of genes in tumor resistance to chemotherapy
JP2004357552A (ja) * 2003-06-03 2004-12-24 Hitachi Ltd 作用物質による効果推定方法及びスクリーニング方法
EP2423331B1 (de) * 2004-03-31 2019-05-08 The General Hospital Corporation Verfahren zur Bestimmung des Ansprechens von Krebs auf den epidermalen Wachstumsfaktorrezeptor gerichtete Behandlungen
JPWO2006082866A1 (ja) * 2005-02-01 2008-06-26 萬有製薬株式会社 ｐ５３の機能異常の検出方法、癌の分子診断方法及び癌治療に有効な化合物の評価方法
AR053272A1 (es) * 2005-05-11 2007-04-25 Hoffmann La Roche Determinacion de responsivos a la quimioterapia

Also Published As

Publication number Publication date
EP1921170A3 (de) 2008-06-04
EP1921170B1 (de) 2009-07-22
JP2008122258A (ja) 2008-05-29
ATE437241T1 (de) 2009-08-15
JP4795203B2 (ja) 2011-10-19
EP1921170A2 (de) 2008-05-14
US7718393B2 (en) 2010-05-18
US20080124750A1 (en) 2008-05-29

Similar Documents

Publication Publication Date Title
WO2008073899A3 (en) Prrg4-associated compositions and methods of use thereof in methods of tumor diagnosis
WO2009085234A3 (en) Use of micro-rna as a biomarker of immunomodulatory drug activity
BRPI0915240A2 (pt) método para tratar câncer, método para avaliação de um paciente submetido ao tratamento de câncer, método para avaliação de um paciente que tem ou com suspeita de ter câncer e uso de um anticorpo anti-c-met
HRP20130618T1 (en) Methods of using mirna for detection of in vivo cell death
EP2118654A4 (de) Diagnostischer test zum nachweis eines moleküls oder arzneistoffs in vollblut
WO2013063155A3 (en) Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
WO2008095492A3 (en) A method for diagnosing atherosclerotic plaques by measurement of cd36
DE602006007814D1 (de) Vorrichtung und Verfahren zum Messen der Durchgangszeit des Sauerstoffes im Blut
MX2009002951A (es) Sistema y metodo para localizar fugas de fluido en un paño de un sistema de suministro de presion reducida.
WO2007079271A3 (en) Techniques for evaluating urinary stress incontinence
WO2010091049A3 (en) Diagnosis and treatment of cancer
WO2009105649A3 (en) Ultrasound guided systems and methods
DE602006009890D1 (de) Verfahren zum Hinzufügen eines Effekts und Vorrichtung zum Hinzufügen eines Effekts
ATE519416T1 (de) Vorrichtung, formulierung und saugfähiges mittel zur sofortigen fleckenentfernung
GB2467467B (en) TAZ/WWTR1 for diagnosis and treatment of cancer
DE502004002547D1 (de) Vorrichtung zum optischen Vermessen eines Objektes
DE602009001116D1 (de) Verfahren zur Erkennung eines oralen Plattenepithelkarzinoms und Mittel zu dessen Unterdrückung
CY1115439T1 (el) Μεθοδοι και νουκλεϊκα οξεα για αναλυσεις διαταραχων του κυτταρικου πολλαπλασιασμου
HK1144711A1 (en) Method and device for determining purification degree and/or performing leakage test
DE502006002308D1 (de) Sondeneinrichtung zur Messung von Prozessgrössen, insbesondere physikalisch-chemischer Messgrössen, in Fluiden
BRPI0507958A (pt) biomarcadores
NZ592994A (en) Diagnostic test for Streptococcus equi comprising assessing the presence or absence of the S. equi eqbE gene
DE602007001656D1 (de) Verfahren zum Ermitteln der Wirksamkeit eines Anthracyclin-Antikrebsmittels
EP2335580A4 (de) Biologische lichtmessungsvorrichtung und positionsanzeigeverfahren zur anzeige einer lichtstrahlenposition und einer lichterkennungsposition oder eines messkanals
WO2009022988A3 (en) Vhz for diagnosis and treatment of cancer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition